Whether discontinuation due to adverse events has affected the statistical analysis of weight regain still required further research for support
Understanding the likely causes is a good starting point
Medicare Bridge enrollment : If you are a Medicare Part D beneficiary, talk to your prescriber about the GLP1 Bridge program starting July 2026
It is not intended for human consumption, veterinary use, cosmetic applications, therapeutic use, or diagnostic purposes
To help you choose wisely, we rounded up the best GLP-1s online for microdosing, and talked to experts about what sets them apart
This is higher than other GLP-1s, which had discontinuation rates of 6.1% (tirzepatide), 8.0% (semaglutide) and 10.3% (orforglipron)